Bausch Health is acquiring DURECT primarily for its lead asset, called larsucosterol. This novel therapeutic molecule is an ...

Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following ...

In his regular browsing on AliExpress, [Ben Jeffrey] came across something he didn’t understand—a $5 fiber optic to RF cable TV adapter. It was excessively cheap, and even more mysteriously, ...

Watching a sci-fi TV show doesn't mean always mean you're dabbling in fantasy - they can be actual windows to the future.

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

From A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it.

In December 2024, Dewpoint Therapeutics CEO Ameet Nathwani said the biotech’s cash runway would last until the third quarter of 2025.

A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist ...

GAAP net loss per share was $(11.29) for Q2 2025, missing the consensus GAAP EPS estimate of $(4.62) by a wide margin, mainly due to a $17.0 million up-front license fee. NextCure advanced both its ...

Stanford engineers have created new VR glasses that are thinner than a credit card and generate lifelike, mixed-reality ...

A novel full-wave rectifier turns an audio power amplifier into a simple modulator, that is then used to modulate an ...

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...